Altered expression of diabetes-related genes in Alzheimer's disease brains: The Hisayama study

Cerebral Cortex

Volumn 24, Issue 9, 2014, Pages 2476-2488

  Hokama, Masaaki ^a,b   Oka, Sugako ^a   Leon, Julio ^a   Ninomiya, Toshiharu ^b   Honda, Hiroyuki ^b   Sasaki, Kensuke ^b   Iwaki, Toru ^b   Ohara, Tomoyuki ^b   Sasaki, Tomio ^b   LaFerla, Frank M ^c   Kiyohara, Yutaka ^b   Nakabeppu, Yusaku ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Hippocampus; Insulin; Microarray; Postmortem brains

Indexed keywords

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; FRONTAL CORTEX; GENE EXPRESSION; GENE MUTATION; HIPPOCAMPUS; HUMAN; INSULIN METABOLISM; MENTAL DISEASE; MICROARRAY ANALYSIS; MICROGLIA; MOUSE; MULTIINFARCT DEMENTIA; NERVE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OLIGODENDROGLIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TEMPORAL CORTEX; ANIMAL; DIABETES MELLITUS; DISEASE MODEL; FEMALE; FRONTAL LOBE; GENETICS; MALE; METABOLISM; TEMPORAL LOBE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; DEMENTIA, VASCULAR; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FEMALE; FRONTAL LOBE; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; MALE; MICE, TRANSGENIC; TEMPORAL LOBE;

EID: 84906987763     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bht101     Document Type: Article

References (51)

1. Abderrahmani A, Niederhauser G, Plaisance V, Roehrich ME, Lenain V, Coppola T, Regazzi R, Waeber G. 2004. Complexin I regulates glucose-induced secretion in pancreatic β-cells. J Cell Sci. 117:2239-2247. (Pubitemid 38807492)
2. Antony S, Kumar TP, Kuruvilla KP, George N, Paulose CS. 2010. Decreased GABA receptor binding in the cerebral cortex of insulin induced hypoglycemic and streptozotocin induced diabetic rats. Neurochem Res. 35:1516-1521.
3. Asanoma K, Kubota K, Chakraborty D, Renaud SJ, Wake N, Fukushima K, Soares MJ, Rumi MA. 2012. SATB homeobox proteins regulate trophoblast stem cell renewal and differentiation. J Biol Chem. 287:2257-2268.
4. Azevedo FA, Carvalho LR, Grinberg LT, Farfel JM, Ferretti RE, Leite RE, Jacob Filho W, Lent R, Herculano-Houzel S. 2009. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol. 513:532-541.
5. Balamotis MA, Tamberg N, Woo YJ, Li J, Davy B, Kohwi-Shigematsu T, Kohwi Y. 2012. Satb1 ablation alters temporal expression of immediate early genes and reduces dendritic spine density during postnatal brain development. Mol Cell Biol. 32:333-347.
6. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B. 57:289-300.
7. Bhatt KV, Spofford LS, Aram G, McMullen M, Pumiglia K, Aplin AE. 2005. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling. Oncogene. 24:3459-3471. (Pubitemid 40756247)
8. Bossers K, Wirz KTS, Meerhoff GF, Essing AHW, van Dongen JW, Houba P, Kruse CG, Verhaagen J, Swaab DF. 2010. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain. 133:3699-3723.
9. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:239-259.
10. Brooks WM, Lynch PJ, Ingle CC, Hatton A, Emson PC, Faull RL, Starkey MP. 2007. Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res. 1127:127-135. (Pubitemid 44872999)
11. Cardozo AK, Heimberg H, Heremans Y, Leeman R, Kutlu B, Kruhoffer M, Orntoft T, Eizirik DL. 2001. A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J Biol Chem. 276:48879-48886.
12. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. 2002. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res. 70:462-473. (Pubitemid 35222383)
13. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR et al. 2012. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 69:29-38.
14. Dandona P, Mohamed I, Ghanim H, Sia CL, Dhindsa S, Dandona S, Makdissi A, Chaudhuri A. 2011. Insulin suppresses the expression of amyloid precursor protein, presenilins, and glycogen synthase kinase-3β in peripheral blood mononuclear cells. J Clin Endocrinol Metab. 96:1783-1788.
15. De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP, Viola KL, Zhao WQ, Ferreira ST, Klein WL. 2009. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A. 106:1971-1976.
16. de la Monte SM, Wands JR. 2008. Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol. 2:1101-1113.
17. Dredge B, Jensen K. 2011. NeuN/Rbfox3 nuclear and cytoplasmic isoforms differentially regulate alternative splicing and nonsensemediated decay of Rbfox2. PLoS One. 6:e21585.
18. Duncan RE, Sarkadi-Nagy E, Jaworski K, Ahmadian M, Sul HS. 2008. Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA). J Biol Chem. 283:25428-25436.
19. Fafalios A, Ma J, Tan X, Stoops J, Luo J, Defrances MC, Zarnegar R. 2011. A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat Med. 17:1577-1584.
20. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S. 2003. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A. 100:4162-4167. (Pubitemid 36418174)
21. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y et al. 2005. Global prevalence of dementia: a Delphi consensus study. Lancet. 366: 2112-2117. (Pubitemid 41797645)
22. Gerritsen ME, Tomlinson JE, Zlot C, Ziman M, Hwang S. 2003. Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells. Br J Pharmacol. 140:595-610. (Pubitemid 37386423)
23. Ghanim H, Monte SV, Sia CL, Abuaysheh S, Green K, Caruana JA, Dandona P. 2012. Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer's disease following gastric bypass surgery. J Clin Endocrinol Metab. 97:E1197-1201.
24. Góra-Kupilas K, Jośko J. 2005. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol. 43:31-39. (Pubitemid 40533190)
25. Gunstad J, Strain G, Devlin MJ, Wing R, Cohen RA, Paul RH, Crosby RD, Mitchell JE. 2011. Improved memory function 12 weeks after bariatric surgery. Surg Obes Relat Dis. 7:465-472.
26. Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, Masliah E. 2010. Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp Neurol. 223:422-431.
27. Katsuki S. 1966. Epidemiological and clinicopathological study on cerebrovascular disease in Japan. Prog Brain Res. 21:64-89.
28. Kay JN, Voinescu PE, Chu MW, Sanes JR. 2011. Neurod6 expression defines new retinal amacrine cell subtypes and regulates their fate. Nat Neurosci. 14:965-972.
29. Kohjima M, Sun Y, Chan L. 2010. Increased food intake leads to obesity and insulin resistance in the Tg2576 Alzheimer's disease mouse model. Endocrinology. 151:1532-1540.
30. Kuusisto J, Koivisto K, Mykkänen L, Helkala EL, Vanhanen M, Hänninen T, Kervinen K, Kesäniemi YA, Riekkinen PJ, Laakso M. 1997. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ. 315:1045-1049. (Pubitemid 27458392)
31. Kuwabara T, Kagalwala M, Onuma Y, Ito Y, Warashina M, Terashima K, Sanosaka T, Nakashima K, Gage F, Asashima M. 2011. Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb. EMBO Mol Med. 3:742-754.
32. Lubik AA, Gunter JH, Hendy SC, Locke JA, Adomat HH, Thompson V, Herington A, Gleave ME, Pollak M, Nelson CC. 2011. Insulin increases de novo steroidogenesis in prostate cancer cells. Cancer Res. 71:5754-5764.
33. Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki S, Kanba S, Kiyohara Y et al. 2010. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology. 75:764-770.
34. Miele C, Rochford JJ, Filippa N, Giorgetti-Peraldi S, Van Obberghen E. 2000. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem. 275:21695-21702. (Pubitemid 30481878)
35. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:479-486.
36. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. 2003. Triple-transgenic model of Alzheimer's disease with plaques and tangles. Neuron. 39:409-421.
37. Ohara T, Ninomiya T, Kubo M, Hirakawa Y, Doi Y, Hata J, Iwaki T, Kanba S, Kiyohara Y. 2011. Apolipoprotein genotype for prediction of Alzheimer's disease in older Japanese: the hisayama study. J Am Geriatr Soc. 59:1074-1079.
38. Parachikova A, Agadjanyan MG, Cribbs DH, Blurton-Jones M, Perreau V, Rogers J, Beach TG, Cotman CW. 2007. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging. 28:1821-1833. (Pubitemid 47539700)
39. Reim K, Wegmeyer H, Brandstatter JH, Xue M, Rosenmund C, Dresbach T, Hofmann K, Brose N. 2005. Structurally and functionally unique complexins at retinal ribbon synapses. J Cell Biol. 169:669-680. (Pubitemid 41002859)
40. Schrijvers EM, Witteman JC, Sijbrands EJ, Hofman A, Koudstaal PJ, Breteler MM. 2010. Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. Neurology. 75:1982-1987.
41. Seidah NG, Benjannet S, Hamelin J, Mamarbachi AM, Basak A, Marcinkiewicz J, Mbikay M, Chretien M, Marcinkiewicz M. 1999. The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. Ann N Y Acad Sci. 885:57-74.
42. Sekita A, Ninomiya T, Tanizaki Y, Doi Y, Hata J, Yonemoto K, Arima H, Sasaki K, Iida M, Iwaki T et al. 2010. Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr Scand. 122:319-325.
43. Sharma S. 2010. Hepatocyte growth factor in synaptic plasticity and Alzheimer's disease. ScientificWorldJournal. 10:457-461.
44. Sherin A, Anu J, Peeyush KT, Smijin S, Anitha M, Roshni BT, Paulose CS. 2012. Cholinergic and GABAergic receptor functional deficit in the hippocampus of insulin-induced hypoglycemic and streptozotocin-induced diabetic rats. Neuroscience. 202:69-76.
45. Sherin A, Peeyush KT, Naijil G, Chinthu R, Paulose CS. 2010. Hypoglycemia induced behavioural deficit and decreased GABA receptor, CREB expression in the cerebellum of streptozoticin induced diabetic rats. Brain Res Bull. 83:360-366.
46. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM. 2005. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis. 7:63-80. (Pubitemid 40387185)
47. Takeda S, Sato N, Uchio-Yamada K, Sawada K, Kunieda T, Takeuchi D, Kurinami H, Shinohara M, Rakugi H, Morishita R. 2010. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A. 107:7036-7041.
48. Tan MG, Chua WT, Esiri MM, Smith AD, Vinters HV, Lai MK. 2010. Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease. J Neurosci Res. 88:1157-1169.
49. Uittenbogaard M, Baxter KK, Chiaramello A. 2010. The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass. ASN Neuro. 2:e00034.
50. Watson E, Hahm S, Mizuno TM, Windsor J, Montgomery C, Scherer PE, Mobbs CV, Salton SR. 2005. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Endocrinology. 146:5151-5163. (Pubitemid 41653029)
51. Zhang M, Poplawski M, Yen K, Cheng H, Bloss E, Zhu X, Patel H, Mobbs CV. 2009. Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling. PLoS Biol. 7:e1000245.